scispace - formally typeset
Open AccessJournal ArticleDOI

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Reads0
Chats0
TLDR
It is shown that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner, which may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.
Abstract
The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis. One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex containing Hrt1 (SCF). We sought to artificially target a protein to the SCF complex for ubiquitination and degradation. To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin. A chimeric compound, protein-targeting chimeric molecule 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF. One domain of Protac-1 contains the IκBα phosphopeptide that is recognized by the F-box protein β-TRCP, whereas the other domain is composed of ovalicin. We show that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner. In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

LYTACs: An Emerging Tool for the Degradation of Non-Cytosolic Proteins

TL;DR: In this article, the authors describe two studies that demonstrate the scope of LYTAC and its advantages over the other protein degradation platforms, including the asialoglycoprotein receptor (ASGPR), which is found only on the surface of liver cells.
Journal ArticleDOI

Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy.

TL;DR: The recent development of ERα peptidomimetic modulators have been considered as promising treatments for drug resistant breast cancers as they are targeting ERα-coactivator interacting interface instead of the ligand binding pocket of ER α.
Journal ArticleDOI

Selectively targeting individual bromodomain: Drug discovery and molecular mechanisms.

TL;DR: In this article, the pioneering progress of bromodomain (BD)selective inhibitors targeting BET and non-BET proteins is summarized, focusing on their structural features, biological activity, therapeutic application and experimental/theoretical mechanisms.
Journal ArticleDOI

Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation.

TL;DR: In this paper , the authors discuss the potential reasons which may underlie this, and present new tools that have been recently developed to solve these limitations and to empower the use of PROTACs to target integral membrane proteins (IMPs).
Journal ArticleDOI

Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology

TL;DR: Cereblon (CRBN) is a substrate receptor of Cullin Ring E3 ubiquitin ligase 4 (CRL4) containing DDB1, CUL4, and RBX1 as mentioned in this paper.
References
More filters
Journal ArticleDOI

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

TL;DR: Recent progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1.
Journal ArticleDOI

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

TL;DR: In this article, a large multiprotein complex, the IkappaB kinase (IKK) signalsome, was purified from HeLa cells and found to contain a cytokine-inducible IKK kinase activity that phosphorylates IappaB-alpha and IKK-beta.
Journal ArticleDOI

SCF and Cullin/RING H2-Based Ubiquitin Ligases

TL;DR: This review is focused on a conserved ubiquitin ligase complex known as SCF that plays a key role in marking a variety of regulatory proteins for destruction by the 26S proteasome.
Journal ArticleDOI

Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27Kip1 induces cell migration

TL;DR: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration and promotes cell migration in mice.
Journal ArticleDOI

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

TL;DR: In this article, the authors used biotinylated-epoxomicin as a molecular probe and showed that it covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome.
Related Papers (5)